COVID-19 vaccines for low- and middle-income countries

被引：56

作者：

Choi, Edward M. ^{[1
]}

机构：

[1] London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England

来源：

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 2021年 / 115卷 / 05期

关键词：

2019 novel coronavirus disease clinical trial; COVID-19; low- and middle-income countries; severe acute respiratory syndrome coronavirus 2; vaccines; SARS-COV-2; VACCINATION; EFFICACY;

D O I：

10.1093/trstmh/trab045

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

The COVID-19 pandemic is the biggest threat to public health in a century. Through hard work and ingenuity, scientists have developed a number of safe and effective vaccines against COVID-19 disease. However, demand far outstrips supply and countries around the world are competing for available vaccines. This review describes how low- and middle-income countries access COVID-19 vaccines, what is being done to distribute vaccines fairly, as well as the challenges ahead.

引用

页码：447 / 456

页数：10

共 55 条

[1]

African Centres for Disease Control and Prevention, 2021, AMSP OP COVID 19 VAC

[2]

[Anonymous], 2020, VACC REL BIOL PROD A

[3]

[Anonymous], 2021, World Bank Open Data

[4] Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer [J].

Avanzato, Victoria A. ;

Matson, M. Jeremiah ;

Seifert, Stephanie N. ;

Pryce, Rhys ;

Williamson, Brandi N. ;

Anzick, Sarah L. ;

Barbian, Kent ;

Judson, Seth D. ;

Fischer, Elizabeth R. ;

Martens, Craig ;

Bowden, Thomas A. ;

de Wit, Emmie ;

Riedo, Francis X. ;

Munster, Vincent J. .

CELL, 2020, 183 (07) :1901-+

[5]

Babu NM, 2021, HINDU

[6] Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial [J].

Buchbinder, Susan P. ;

Mehrotra, Devon V. ;

Duerr, Ann ;

Fitzgerald, Daniel W. ;

Mogg, Robin ;

Li, David ;

Gilbert, Peter B. ;

Lama, Javier R. ;

Marmor, Michael ;

del Rio, Carlos ;

McElrath, M. Juliana ;

Casimiro, Danilo R. ;

Gottesdiener, Keith M. ;

Chodakewitz, Jeffrey A. ;

Corey, Lawrence ;

Robertson, Michael N. .

LANCET, 2008, 372 (9653) :1881-1893

[7] Use of adenovirus type-5 vectored vaccines: a cautionary tale [J].

Buchbinder, Susan P. ;

McElrath, M. Juliana ;

Dieffenbach, Carl ;

Corey, Lawrence .

LANCET, 2020, 396 (10260) :E68-E69

[8]

Burnett E, 2020, LANCET GLOB HEALTH, V8, pE1195, DOI 10.1016/S2214-109X(20)30262-X

[9] Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic [J].

Buss, Lewis F. ;

Prete Jr, Carlos A. ;

Abrahim, Claudia M. M. ;

Mendrone Jr, Alfredo ;

Salomon, Tassila ;

de Almeida-Neto, Cesar ;

Franca, Rafael F. O. ;

Belotti, Maria C. ;

Carvalho, Maria P. S. S. ;

Costa, Allyson G. ;

Crispim, Myuki A. E. ;

Ferreira, Suzete C. ;

Fraiji, Nelson A. ;

Gurzenda, Susie ;

Whittaker, Charles ;

Kamaura, Leonardo T. ;

Takecian, Pedro L. ;

Peixoto, Pedro da Silva ;

Oikawa, Marcio K. ;

Nishiya, Anna S. ;

Rocha, Vanderson ;

Salles, Nanci A. ;

de Souza Santos, Andreza Aruska ;

da Silva, Martirene A. ;

Custer, Brian ;

Parag, Kris, V ;

Barral-Netto, Manoel ;

Kraemer, Moritz U. G. ;

Pereira, Rafael H. M. ;

Pybus, Oliver G. ;

Busch, Michael P. ;

Castro, Marcia C. ;

Dye, Christopher ;

Nascimento, Vitor H. ;

Faria, Nuno R. ;

Sabino, Ester C. .

SCIENCE, 2021, 371 (6526) :288-+

[10]

Centers for Disease Control and Prevention, 2020, IF YOU AR IMM PROT Y

← 1 2 3 4 5 6 →